PTHrP-Induced Refractory Malignant Hypercalcemia in a Patient With Chronic Lymphocytic Leukemia Responding to Denosumab

Saved in:
Bibliographic Details
Published in:Clinical lymphoma, myeloma and leukemia myeloma and leukemia, 2015-09, Vol.15 (9), p.e137-e140
Main Authors: Salahudeen, Ameen A, Gupta, Arjun, Jones, Jeremy C, Cowan, Robert W, Vusirikala, Madhuri, Kwong, Chi, Naina, Harris V.K
Format: Article
Language:English
Subjects:
Adult
CLL
Denosumab
Denosumab - therapeutic use
Hematology, Oncology and Palliative Medicine
Humans
Humoral hypercalcemia
Hypercalcemia - drug therapy
Hypercalcemia - metabolism
Hypercalcemia - pathology
Hypercalcemia of malignancy
Leukemia, Lymphocytic, Chronic, B-Cell - metabolism
Leukemia, Lymphocytic, Chronic, B-Cell - pathology
Male
Paraneoplastic Syndromes - drug therapy
Paraneoplastic Syndromes - metabolism
Paraneoplastic Syndromes - pathology
Parathyroid Hormone-Related Protein - metabolism
Parathyroid hormone–related protein
PTHrP
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:2152-2650
2152-2669
DOI:10.1016/j.clml.2015.06.007